Several results from cancer studies have been shown that GAPLNC can modulate the expression of Bcl‐2 by down‐regulating miR‐211.14, 21 Here, we tested this hypothesis by either silencing or overexpressing GAPLINC in HUEVC cells. Here, BCL2 is linked to cancer.